Mandate

Vinge advises NOTE in connection with the company’s underwritten rights issue

March 11, 2010

Vinge is advising NOTE AB (publ) in connection with the new issue of shares for approximately SEK 87 million with pre-emption rights for NOTE’s shareholders. The rights issue is conditional upon approval by the members at an extraordinary general meeting to be held on 7 April 2010. The new issue is fully underwritten by a subscription agreement and guarantee commitment by NOTE’s major shareholders.

NOTE is listed on NASDAQ OMX Stockholm. Note’s business concept is to provide electronics manufacturing and logistics services.

Vinge’s team consisted of Ola Sandersson, Dain Nevonen and Christian Granqvist. Bo Adrianzon is the responsible partner.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025